VR Logo

Chembio Diagnostics Inc. (CEMI) download report


Healthcare | Diagnostics Services

Chembio Diagnostics Inc. (CEMI) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases.

IPO Date: 18-Oct-2000

Pres, CEO & Director: Mr. Richard L. Eberly

Exec. VP and Chief Scientific & Technology Officer: Mr. Javan Esfandiari

Listing: NASDAQ: CEMI

Country: United States

Headquarters: Hauppauge, NY

Website: https://chembio.com

Key Facts

Market cap: $19.20 Mln

Revenue (TTM): $53.23 Mln

Earnings (TTM): $-38.19 Mln

Cash: $24.40 Mln

Total Debt: $25.81 Mln

Insider's Holding: 1.31%

Liquidity: Low

52 Week range: $0.42 - 7.34

Shares outstanding: 30,221,900

10 Years Aggregate:

  • CFO: $-81.34 Mln
  • EBITDA: $-84.52 Mln
  • Net Profit: $-102.75 Mln

Stock Performance

Time Period Chembio Diagnostics (CEMI) S&P BSE Sensex S&P Small-Cap 600
YTD-36.85-7.86-19.79
1 month-0.01-3.75-9.59
3 months-5.28-10.80-13.28
1 Year-75.181.50-17.92
3 Years-50.0610.755.46
5 Years-35.3011.435.57
10 Years-16.8911.849.48
As on 06-Jul-2022
Year Chembio Diagnostics (CEMI) S&P Small-Cap 600 S&P BSE Sensex
2021-76.0025.2721.99
20204.179.5715.75
2019-19.4320.8614.38
2018-30.84-9.705.87
201720.5911.7327.91
201627.5824.741.95
201536.32-3.36-5.03